BN Business News
Add your company to Business Communicator →

Business · 23/10/20261 min read

ImmunoForge to showcase proprietary platform technologies and next-generation oncology & Phase 2 clinical pipelines at BIO-Europe 2026

Summary

Seoul, South Korea and COLOGNE, Germany, October 22, 2026 — ImmunoForge Co., Ltd. , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →